Researchers from IOCB Prague have succeeded in preparing compounds capable of activating prodrugs at predetermined locations in the body, enhancing their effectiveness and expediting their action.

Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address. Prodrugs are medications that start as inactive or less active, ...

Prodrugs are medications that start as inactive or less active, and once inside the body, are converted into the active form, ...

Get article recommendations from ACS based on references in your Mendeley library. Pair your accounts.

(NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that an abstract related to the company’s ...

The Danish pharma group is pledging $285 million in upfront and milestone payments for the lead GLP-1 asset in the ...

MAIA will present the results of preclinical studies for its new THIO-based prodrugs, designated as MAIA-2021-20 and MAIA-2022-12, which are lipid-conjugated compounds derived from THIO.

Get article recommendations from ACS based on references in your Mendeley library. Pair your accounts.

Detailed price information for Thiogenesis Therapeutics Corp (TTI-X) from The Globe and Mail including charting and trades.

NanoViricides, Inc. (NYSE Amer.: NNVC ) (the “Company”), a clinical stage global leader in broad-spectrum antiviral ...